Erismen Agan Beste, Uyanık Lokman Onur, Donmezer Ceren Melahat
Department of Oral and Maxillofacial Surgery, Near East University Faculty of Dentistry, Nicosia, Mersin-10, Turkey.
BMC Oral Health. 2025 Mar 25;25(1):427. doi: 10.1186/s12903-025-05828-3.
This study investigates the postoperative benefits of low-level laser therapy (LLLT) and platelet-rich fibrin (PRF) in enhancing patient comfort and reducing complications after mandibular third molar extractions.
Sixty patients with vertically impacted mandibular third molars were randomly assigned to one control and three test groups (n = 15 each). In Group 1, PRF was applied to the socket post-extraction. In Group 2, PRF was combined with LLLT (B-Cure Dental Laser, 808 nm wavelength, 4 J/cm² energy density, continuous wave) applied extra-orally for three days post-surgery. Group 3 received LLLT alone. Group 4 (control group) underwent traditional osteotomy without additional treatments. All patients were prescribed 875/125 mg amoxicillin/clavulanic acid twice daily for five days.
Postoperative parameters such as pain, swelling, analgesic use, and trismus were assessed on days 1, 2, 3, and 7. Significant improvements in pain, swelling, and trismus were observed in Groups 2 and 3 compared to the control (p < 0.001). Swelling was also significantly reduced in Group 1 compared to the control.
The study demonstrated favorable clinical outcomes in the LLLT and PRF groups, suggesting that both treatments could be promising strategies for improving postoperative recovery in terms of comfort and reduced complications.
Clinicaltrials.gov ID: NCT06262945. The trial was first registered on 16/02/2024. Retrospectively registered.
本研究调查了低强度激光疗法(LLLT)和富血小板纤维蛋白(PRF)在下颌第三磨牙拔除术后提高患者舒适度和减少并发症方面的益处。
60例垂直阻生下颌第三磨牙患者被随机分为1个对照组和3个试验组(每组n = 15)。第1组在拔牙后将PRF应用于牙槽窝。第2组在术后3天额外使用PRF联合LLLT(B - Cure牙科激光,波长808 nm,能量密度4 J/cm²,连续波)进行口外照射。第3组仅接受LLLT。第4组(对照组)采用传统截骨术,不进行额外治疗。所有患者均被处方875/125 mg阿莫西林/克拉维酸,每日两次,共5天。
在第1、2、3和7天评估术后参数,如疼痛、肿胀、镇痛药物使用和张口受限情况。与对照组相比,第2组和第3组在疼痛、肿胀和张口受限方面有显著改善(p < 0.001)。与对照组相比,第1组的肿胀也显著减轻。
该研究表明LLLT组和PRF组有良好的临床结果,提示这两种治疗方法在提高术后舒适度和减少并发症方面可能是有前景的策略。
Clinicaltrials.gov标识符:NCT06262945。该试验于2024年2月16日首次注册。回顾性注册。